BCMA Knockout RPMI-8226 Cell Line from BPS Bioscience, Inc.

Description

BCMA Knockout RPMI-8226 Cell Line is an RPMI-8226 cell line in which BCMA (B-Cell Maturation Antigen, or CD269) has been genetically removed from RPMi-8226 cells using CRISPR/Cas9 genome editing by RNP (ribonucleoprotein) electroporation. This cell line has been validated by genome sequencing and flow cytometry

Product Specs
ItemBCMA Knockout RPMI-8226 Cell Line
CompanyBPS Bioscience, Inc.
Price $5,500.00Supplier Page View Company Product Page
Catalog Number82659
TypeCell Line
ApplicationsUse as negative control in the development of biologics targeting BCMA. Use as a control in CAR-T or NK co-culture killing assays
Source/Expression SystemRPMI-8226, human B cells isolated from a plasmacytoma/myeloma patient, suspension
human
Quantity2 vials